POINT Biopharma Global Inc. - Common Stock (NQ:PNT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 26, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about POINT Biopharma Global Inc. - Common Stock

< Previous 1 2 3 4 Next >

Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2022

Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.

Via Benzinga

Nucor, Altimmune And Some Other Big Stocks Moving Lower On Wednesday ↗

September 14, 2022

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Thanks To Encouraging Data, These Mid-Cap Stocks Layout $300M Equity Raise ↗

September 14, 2022

Via Benzinga

POINT Biopharma Shares Jump After Updated Efficacy, Safety Data From Prostate Cancer Candidate ↗

September 12, 2022

Via Benzinga

Recap: POINT Biopharma Global Q2 Earnings ↗

August 12, 2022

POINT Biopharma Global (NASDAQ:PNT) reported its Q2 earnings results on Friday, August 12, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why POINT Biopharma Shares Are Getting Hammered ↗

September 14, 2022

POINT Biopharma Global Inc (NASDAQ: PNT) shares are trading lower by 11.41% to $9.01 Wednesday morning after the company priced a public offering of 13.9 million shares of common stock at $9 per share....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022 ↗

September 14, 2022

Upgrades For Iris Energy Ltd (NASDAQ:IREN), Compass Point upgraded the previous rating of Neutral to Buy. The current stock performance of Iris Energy shows a 52-week-high of $17.97 and a 52-week-low...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 14, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 14, 2022

We're starting off Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares!

Via InvestorPlace

Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.

Via Benzinga

Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session ↗

September 12, 2022

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗

September 07, 2022

Upgrades

Via Benzinga

Peering Into POINT Biopharma Global's Recent Short Interest ↗

September 07, 2022

POINT Biopharma Global's (NASDAQ:PNT) short percent of float has fallen 3.57% since its last report. The company recently reported that it has 12.90 million shares sold short...

Via Benzinga

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday ↗

September 07, 2022

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 06, 2022

Via Benzinga

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session ↗

September 06, 2022

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022 ↗

August 16, 2022

Via Benzinga

Earnings Scheduled For August 12, 2022 ↗

August 12, 2022

Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million.

Via Benzinga

Preview: POINT Biopharma Global's Earnings ↗

August 11, 2022

POINT Biopharma Global (NASDAQ:PNT) is set to give its latest quarterly earnings report on Friday, 2022-08-12. Here's what investors need to know before the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022 ↗

July 06, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022 ↗

May 26, 2022

Upgrades

Via Benzinga

Earnings Scheduled For May 13, 2022 ↗

May 13, 2022

Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million.

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

March 28, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron....

Via Benzinga

50 Biggest Movers From Yesterday ↗

March 29, 2022

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 28, 2022

Gainers OncoSec Medical (NASDAQ:ONCS) shares moved upwards by 27.1% to $1.5 during Monday's pre-market session. The company's market cap stands at $59.0 million....

Via Benzinga

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO ↗

March 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Earnings Scheduled For March 25, 2022 ↗

March 25, 2022

Companies Reporting Before The Bell DXP Enterprises, Inc. (NASDAQ: DXPE) is expected to report quarterly earnings at $0.14 per share on revenue of $285.00 million. BRP...

Via Benzinga

This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers ↗

March 22, 2022

Photo by National Cancer Institute on Unsplash

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 21, 2022

Gainers Mustang Bio (NASDAQ:MBIO) shares ...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.